On Thursday, Shares of Boston Scientific Corporation (NYSE:BSX), subtract -0.13% and closed at $23.15 in the last trading session. The last trading range of the stock ranges between $22.88 and $23.25. Boston Scientific Corporation (BSX) declared recently that Professor Ian Meredith AM will join the company as executive vice president and global chief medical officer in January 2017. In his new position, Professor Meredith will lead clinical and medical affairs across Boston Scientific and will provide global leadership of the company’s clinical trial strategy.
Professor Meredith will succeed Executive Vice President and Global Chief Medical Officer Keith Dawkins, M.D., who has declared his intention to retire from the company in January 2017.
“Ian is one of the world’s leading cardiac device clinical investigators and he has been an advisor to Boston Scientific for many years,” said Mike Mahoney, chairman and chief executive officer, Boston Scientific. “His strong relationships within the global research and clinical community and his track record applying novel technologies to advance science and care for patients make him ideally suited to drive innovation and succeed Keith in this role. We are delighted that he will be joining our team.”
EnteroMedics Inc (NASDAQ:ETRM), jumped 4.96% and closed at $0.110 in the last trading session. The last trading range of the stock ranges between $0.10 and $0.12. The company’s Market capitalization is $7.30 Billion with the total outstanding Shares of 69.70 million. EnteroMedics Inc. (ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, recently urged shareholders of record at the close of business on September 14, 2016 to vote FOR all of the administration proposals at the forthcoming special meeting of shareholders, to be held on Wednesday, October 19, 2016.
Each of the administration proposals is an important element of EnteroMedics’ plan to maintain its listing on the The Nasdaq Capital Market and fund its future operations and development. EnteroMedics’ future opportunities include its recently declared distribution agreement to supply vBloc Therapy to U.S. veterans at VA facilities at little to no cost to veterans in accordance with their veterans’ health benefits.
Dominion Resources, Inc. (NYSE:D), jumped 1.59% and closed at $73.31 in the last trading session. The last trading range of the stock ranges between $72.09 and $73.88. During the 52-week trading session the minimum price at which share price traded, registered at $64.54 and reached to max level of $78.97. Dominion Virginia Power crews made steady progress over the weekend, restoring power to more than 70 percent of the 462,000 customers influenced by Hurricane Matthew since 4 p.m. Saturday. As of 6 a.m. Monday, 136,600 customers remain without power at 3,600 work locations.
The majority of those influenced are in southeastern Virginia and northeastern North Carolina, where historic rainfall, high winds and saturated ground combined to cause extensive damage to roads, bridges and electrical infrastructure. Damage included broken poles, cross arms and downed wire in many locations. Extremely hazardous flooding conditions and high winds over the weekend made it too dangerous to use bucket trucks and hampered our ability to at first make repairs at hard-hit locations.=
Since the storm impacts lasted well into yesterday, recently is our first full day of restoration. Our crews are out in force and will continue to focus on damage assessments and restoration to critical services such as 911 centers, water pumping stations and hospitals. There were 433 critical services affected by the storm and, as of this morning, 87 percent of them had been restored.